{
  "doc_id": "Fibrosing-Mediastinitis",
  "doc_filename": "Fibrosing-Mediastinitis.pdf",
  "top_entities": [
    {
      "name": "fungal infectious disease",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "fibrosing mediastinitis",
      "mention_count": 1,
      "entity_type": "disease"
    }
  ],
  "file_size_bytes": 1791,
  "file_size_human": "1.7 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:18",
  "doi": null,
  "doi_url": null,
  "document_type_code": "DLA",
  "document_type_name": "Disease Landscape Analysis",
  "document_type_group": "Disease Landscape Analysis",
  "classification_confidence": 0.85,
  "title": "Fibrosing Mediastinitis: Epidemiology and Population Prevalence",
  "short_description": "Clinical document discussing the prevalence and population distribution of fibrosing mediastinitis, particularly related to histoplasmosis infection.",
  "long_description": "This clinical research document examines the epidemiological aspects of fibrosing mediastinitis (FM), a rare condition characterized by excessive healing response to fungal infections. The document provides prevalence estimates, noting that less than 1% of histoplasmosis patients develop FM, with only several hundred cases of histoplasmosis-related FM and several dozen cases of idiopathic FM estimated in the United States. It emphasizes the geographic limitation of post-histoplasmosis FM to individuals with exposure to endemic regions and highlights the rarity of this condition in the general population.",
  "document_date": "2026-01-07T22:25:18",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T04:36:55.463009"
}